ABSTRACT OBJECTIVES This study sought to evaluate whether frailty improves mortality prediction in combination with the conventional scores.
R isk stratification before transcatheter aortic valve implantation (TAVR) is important when selecting those patients with severe aortic stenosis who will most likely benefit from the intervention. The Society of Thoracic Surgeons (STS) score and European System for Cardiac Operative Risk Evaluation (EuroSCORE) are frequently used for risk evaluation before TAVR, but both have been developed for conventional cardiac surgery procedures and are therefore not precise and complete enough for patients being considered for TAVR (1) (2) (3) (4) (5) (6) . So far, TAVRspecific variables are missing in conventional risk scores. In recent years, evidence has grown that functional assessment, in particular frailty measures, may improve risk stratification in patients undergoing TAVR (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) .
So far, the previous studies provided evidence that frailty measures are predictors of worse outcomes independent of the conventional risk scores (STS score or EuroSCORE) and thus have the potential to improve risk prediction of the conventional risk scores (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . However, no previous study has eval- We also excluded patients who died while waiting for TAVR and patients in whom the time between geriatric baseline examination and TAVR was >3 months.
The final study population consisted of all patients in whom TAVR and the geriatric baseline examination was performed during the study period. This study complies with the Declaration of Helsinki and was approved by the local ethics committee. Schoenenberger et al. (29) .
Improvement of Risk Prediction After TAVR
If the LR chi-square test difference from the latter is greater than from the former, then the frailty index adds more to the combined model than the cardio- 
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(95% CI: 0.13 to 0.23). HR ¼ hazard ratio; other abbreviations as in Tables 1 and 2 .
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TAVR patients (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . However, only few studies showed that functional measures predict outcomes independent of the conventional risk scores (STS score or EuroSCORE) and thus have the potential to improve risk prediction (7, (11) (12) (13) 15) . None of the previous studies proved that risk prediction of the conventional risk scores (STS score or EuroSCORE) is truly improved in combined prediction models (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) .
In a preliminary analysis of an initial subsample of the present cohort, the number of participants and the respective number of endpoints were not powered to document an improvement ( Our study also shows that 1-year mortality increases with increasing frailty. We previously showed that frailty may also be the consequence of severe aortic stenosis and may be reversed by TAVR (8) .
However, this study suggests that there might be a level of frailty, which is irreversible. One-year mortality in the highest 2 frailty categories exceeded 50%, and this mortality rate might be considered unacceptably high for performing TAVR. Therefore, our frailty index might have the potential to guide triage in patients being evaluated for TAVR and to recommend palliative treatment in these highestrisk patients. As the number of patients was low in the 2 highest frailty categories, it is too early to derive clinical recommendations from our findings, but we see an urgent need for further research in this field. In addition to triage patients, using a frailty index based on MGA has further advantages. In contrast to other frailty scores, information from MGA (e.g., information on cognition, mobility, nutrition, disability) may be used to improve therapeutic decisions.
Among the components of the frailty index, the TUG was the functional measure with the best prediction of 1-year mortality. Hereby, our study confirms the findings of a previous study showing that mobility impairment is extremely important for the prediction of adverse outcomes (10). Our study documents that it is important to use performance-based tests such as the TUG, and not measures based on self-report such as preclinical mobility disability.
Whereas the TUG was an excellent predictor, preclinical mobility disability was not.
STUDY LIMITATIONS. First, patients who underwent TAVR were a selection of elderly, high-risk patients.
Older patients with low risk were frequently allocated to open heart surgery, whereas elderly patients with excessive risk were sometimes assigned to medical treatment. Therefore, the predictive value of the frailty index has to be reconfirmed in patients with lower risk. Second, the results of this study are based on data from a single center.
Therefore, confirmation in an independent sample would be needed to document generalizability of our findings. Nevertheless, there is meanwhile enough evidence supporting the importance of frailty measures in the risk prediction of patients undergoing TAVR and surgical procedures (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) 41) . 
CONCLUSIONS
The present study provides evidence that our frailty index enhances the risk prediction of conventional risk models in patients undergoing TAVR. We therefore recommend adding frailty assessment to conventional risk scores such as STS score or Euro-SCORE. In addition, our frailty index has the potential to triage patients, because interventional risk is unacceptably high in the highest frailty categories. have not been evaluated in combined models with frailty for mortality prediction after TAVR.
WHAT IS NEW? The assessment of frailty significantly enhances prediction of 1-year mortality after TAVR in combined risk models with the conventional risk scores. Frailty should be measured in all patients who undergo TAVR before the intervention.
WHAT IS NEXT? Frailty should be added to the currently used conventional risk scores. The best way to assess frailty and to combine the information from frailty assessment with the conventional risk scores requires further investigation.
